Wegovy vs Ozempic: What is the difference?
Wegovy and Ozempic are two different brand names for the same medication, semaglutide. Ozempic is FDA-approved to treat type 2 diabetes. Wegovy is FDA-approved at different doses for chronic weight management.
- Wegovy and Ozempic both contain semaglutide.
- Ozempic is approved for type 2 diabetes and related conditions.
- Wegovy is approved for chronic weight management and reducing cardiovascular risk in certain people.
- Insurance coverage and prior authorization requirements differ between the two medications.
The active ingredient: semaglutide
Wegovy and Ozempic are both brand names for a medication called semaglutide. They are manufactured by the same company, Novo Nordisk. Semaglutide belongs to a class of medications called GLP-1 receptor agonists.
GLP-1 medications mimic a hormone naturally produced in your gut. They signal to your brain that you are full. They also slow down how quickly food leaves your stomach. This helps reduce appetite and food intake.
While the active ingredient is the same, the two medications have different FDA approvals, different dosing schedules and different target patient populations.
Ozempic: type 2 diabetes
The FDA approved Ozempic in 2017 to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with type 2 diabetes and established cardiovascular disease.
Ozempic is available in pens that deliver doses of 0.25 mg, 0.5 mg, 1 mg or 2 mg of semaglutide.
Ozempic is not FDA-approved for weight loss. While weight loss is a known side effect in people taking Ozempic for diabetes, it is prescribed specifically for blood sugar management.
Wegovy: chronic weight management
The FDA approved Wegovy in 2021 for chronic weight management in adults with obesity, or overweight with at least one weight-related condition like high blood pressure, type 2 diabetes or high cholesterol. It is meant to be used along with a reduced-calorie diet and increased physical activity.
In 2024, the FDA also approved Wegovy to reduce the risk of major cardiovascular events in adults with cardiovascular disease and either obesity or overweight.
Wegovy is available in single-dose pens that deliver 0.25 mg, 0.5 mg, 1 mg, 1.7 mg or 2.4 mg of semaglutide. The maximum maintenance dose for Wegovy (2.4 mg) is higher than the maximum dose for Ozempic (2.0 mg).
Insurance and access
Because Ozempic and Wegovy have different FDA approvals, insurance companies treat them differently. Health insurance plans often cover Ozempic for patients with a confirmed diagnosis of type 2 diabetes.
Coverage for Wegovy is less common. Many insurance plans do not cover anti-obesity medications. Those that do cover Wegovy usually require prior authorization. This means your physician must submit paperwork showing you meet specific criteria before the plan will pay for the medication.
Insurance coverage and prior authorization for medications depend on your plan and are never guaranteed.
What about Mounjaro and Zepbound?
A similar situation exists with another medication called tirzepatide, manufactured by Eli Lilly. Like semaglutide, tirzepatide is sold under two different brand names for two different uses.
Mounjaro is the brand name for tirzepatide when it is FDA-approved to treat type 2 diabetes. Zepbound is the brand name for tirzepatide when it is FDA-approved for chronic weight management.
Just like Ozempic, Mounjaro is not FDA-approved for weight loss. It is prescribed for blood sugar control in people with type 2 diabetes.
Safety considerations for GLP-1 medications
All GLP-1 medications, including Wegovy, Ozempic, Zepbound and Mounjaro, carry a boxed warning from the FDA regarding a potential risk of thyroid C-cell tumors. This includes medullary thyroid carcinoma. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take these medications.
Other potential serious side effects include pancreatitis, gallbladder problems, kidney issues and severe allergic reactions. Common side effects are often gastrointestinal, such as nausea, vomiting, diarrhea, stomach pain and constipation. These typically occur when starting the medication or increasing the dose.
Decisions about starting, stopping or changing any medication should be made with your physician.
Medical weight management at Éblouissant
At Éblouissant, Dr. Pandey provides comprehensive medical weight management. An initial weight consultation is 30 to 45 minutes and includes a physician evaluation, metabolic and thyroid blood work, and nutrition counseling.
When clinically appropriate in her judgment, Dr. Pandey may prescribe FDA-approved medications, including GLP-1 based medicines like Wegovy or Zepbound.
We are located in Greenwich Village, New York City. You can book an appointment online through our patient portal or by calling our office.
Common questions
Can I switch from Ozempic to Wegovy?
Switching between medications depends on your medical diagnosis and your insurance coverage. Your physician will determine which medication is appropriate based on whether you have type 2 diabetes or are seeking treatment for chronic weight management.
Is the highest dose of Wegovy more effective than Ozempic for weight loss?
Wegovy is approved for chronic weight management at a maximum dose of 2.4 mg. Ozempic is approved for type 2 diabetes at a maximum dose of 2.0 mg. The clinical trial known as STEP 1 showed that patients taking semaglutide 2.4 mg lost about 15% of their body weight over 68 weeks. Results vary by individual.
Why would my doctor prescribe Wegovy instead of Ozempic?
Your doctor will prescribe the medication that aligns with its FDA-approved indication. If you need treatment for chronic weight management and do not have type 2 diabetes, Wegovy is the appropriate FDA-approved option.
Will my insurance cover Wegovy?
Insurance coverage for Wegovy varies widely by plan. Many plans exclude coverage for anti-obesity medications, while others require prior authorization. You will need to check directly with your insurance provider to understand your specific benefits.
Medical Weight Loss & GLP-1
See pricing, what to expect, and how to book on our Medical Weight Loss & GLP-1 page.
Related reading
This article is general information, not medical advice, and does not create a doctor-patient relationship. Individual results vary. If you have a medical emergency, call 911. Medical disclaimer